Cecilia Volk, PharmD
@ccvolk.bsky.social
Infectious Disease Pharmacist - Assistant Professor @ UW Madison
Reposted by Cecilia Volk, PharmD
@ccvolk.bsky.social teaching us about TDM of dapto, dalba, and orita @sidpharm.bsky.social @escmid.bsky.social PK/PD conference!
🔑 Consider flat based dosing of dapto
🔑 You may be able to extend abx coverage duration by 2 wks by giving 1.5g dalba x2 but 21 days apart
🔑Orita: still limited data
🔑 Consider flat based dosing of dapto
🔑 You may be able to extend abx coverage duration by 2 wks by giving 1.5g dalba x2 but 21 days apart
🔑Orita: still limited data
June 3, 2025 at 7:34 PM
@ccvolk.bsky.social teaching us about TDM of dapto, dalba, and orita @sidpharm.bsky.social @escmid.bsky.social PK/PD conference!
🔑 Consider flat based dosing of dapto
🔑 You may be able to extend abx coverage duration by 2 wks by giving 1.5g dalba x2 but 21 days apart
🔑Orita: still limited data
🔑 Consider flat based dosing of dapto
🔑 You may be able to extend abx coverage duration by 2 wks by giving 1.5g dalba x2 but 21 days apart
🔑Orita: still limited data
Honored to have been part of this amazing event! Can’t thank the organizers enough for all the work they put in to make this such a valuable experience! @sidpharm.bsky.social @escmid.bsky.social
the first ever @sidpharm.bsky.social and @escmid.bsky.social PK PD workshop is in full swing and it’s AMAZING
so many brilliant minds in this room with the highest quality presentations
#idsky #medsky #amssky
so many brilliant minds in this room with the highest quality presentations
#idsky #medsky #amssky
June 4, 2025 at 4:39 AM
Honored to have been part of this amazing event! Can’t thank the organizers enough for all the work they put in to make this such a valuable experience! @sidpharm.bsky.social @escmid.bsky.social
Reposted by Cecilia Volk, PharmD
Be sure to join Dr. @ccvolk.bsky.social as she shares her team's experience with long term dalbavancin use & PK estimates at #ESCMIDGlobal 2025!
Monthly dosing of dalbavancin for suppression supported by both PK modeling & a case series showing no treatment failure or infection recurrence 💉
Monthly dosing of dalbavancin for suppression supported by both PK modeling & a case series showing no treatment failure or infection recurrence 💉
April 13, 2025 at 10:30 AM
Be sure to join Dr. @ccvolk.bsky.social as she shares her team's experience with long term dalbavancin use & PK estimates at #ESCMIDGlobal 2025!
Monthly dosing of dalbavancin for suppression supported by both PK modeling & a case series showing no treatment failure or infection recurrence 💉
Monthly dosing of dalbavancin for suppression supported by both PK modeling & a case series showing no treatment failure or infection recurrence 💉
Reposted by Cecilia Volk, PharmD
it’s the happiest Thursday because @sidpharm.bsky.social and the @escmid.bsky.social PK PD study group are bringing back ICAAC (in spirit)!!!!
Registration will open next week! The Midwest in the summer is magical - come join us!
sidp.org/page-1543694
#idsky #amssky #pharmsky
Registration will open next week! The Midwest in the summer is magical - come join us!
sidp.org/page-1543694
#idsky #amssky #pharmsky
December 5, 2024 at 12:52 PM
it’s the happiest Thursday because @sidpharm.bsky.social and the @escmid.bsky.social PK PD study group are bringing back ICAAC (in spirit)!!!!
Registration will open next week! The Midwest in the summer is magical - come join us!
sidp.org/page-1543694
#idsky #amssky #pharmsky
Registration will open next week! The Midwest in the summer is magical - come join us!
sidp.org/page-1543694
#idsky #amssky #pharmsky